DUBLIN, July 16, 2025--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract ...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced the discontinuation of its Phase 3 ICoN-1 clinical trial evaluating ...
Dublin, Ireland, 20 January, 2014 – ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced ...
SUNNYVALE, Calif., May 06, 2014 (BUSINESS WIRE) -- Icon Bioscience, Inc., a specialty biopharmaceutical company focused on utilizing its Verisome® drug-delivery platform to develop unique intraocular ...
DOWNTOWN MAY LOOK LIKE. WELL, STEVE, THE DES MOINES METROPOLITAN PLANNING AND ORGAN PLANNING ORGANIZATION VOTED TUESDAY TO APPROVE THE $40.9 MILLION BID. THE MPO SAYS THAT FALLS WITHIN THEIR BUDGET.
Icon Aircraft has completed the first phase of the Icon A5 light sport aircraft flight-testing programme. The two-seat amphibian has completed 27 flights from which "data was gathered across a wide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback